Epigenetic control of immunity

Cold Spring Harbor Perspectives in Biology

Volumn 6, Issue 6, 2014, Pages

  Busslinger, Meinrad ^a   Tarakhovsky, Alexander ^b  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; CELL LINEAGE; CYTOLOGY; GENETIC EPIGENESIS; GENETICS; HUMAN; IMMUNITY; IMMUNOLOGY; LYMPHOCYTE;

ADAPTIVE IMMUNITY; CELL LINEAGE; EPIGENESIS, GENETIC; HUMANS; IMMUNITY; LYMPHOCYTES;

EID: 84887206943     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a019307     Document Type: Article

References (140)

1. Adelman K, Lis JT. 2012. Promoter-proximal pausing of RNA polymerase II: Emerging roles in metazoans. Nat Rev Genet 13: 720-731.
2. Bacher CP, Guggiari M, Brors B, Augui S, Clerc P, Avner P, Eils R, Heard E. 2006. Transient colocalization of X-inactivation centres accompanies the initiation of X inactivation. Nat Cell Biol 8: 293-299.
3. Bai L, Morozov AV. 2010. Gene regulation by nucleosome positioning. Trends Genet 26: 476-483.
4. Bai L, Ondracka A, Cross FR. 2011. Multiple sequence-specific factors generate the nucleosome-depleted region on CLN2 promoter. Mol Cell 42: 465-476.
5. Balazsi G, van Oudenaarden A, Collins JJ. 2011. Cellular decision making and biological noise: From microbes to mammals. Cell 144: 910-925.
6. Bassing CH, Swat W, Alt FW. 2002. The mechanism and regulation of chromosomal V(D)J recombination. Cell 109: S45-S55.
7. Bereshchenko OR, Gu W, Dalla-Favera R. 2002. Acetylation inactivates the transcriptional repressor BCL6. Nat Genet 32: 606-613.
8. Bhatt DM, Pandya-Jones A, Tong AJ, Barozzi I, Lissner MM, Natoli G, Black DL, Smale ST. 2012. Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractions. Cell 150: 279-290.
9. Blake WJ, Kærn M, Cantor CR, Collins JJ. 2003. Noise in eukaryotic gene expression. Nature 422: 633-637.
10. Bolland DJ, Wood AL, Johnston CM, Bunting SF, Morgan G, Chakalova L, Fraser PJ, Corcoran AE. 2004. Antisense intergenic transcription in V(D)J recombination. Nat Immunol 5: 630-637.
11. Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K. 2003. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J 22: 5323-5335.
12. Bussmann LH, Schubert A, Vu Manh TP, De Andres L, Desbordes SC, Parra M, Zimmermann T, Rapino F, Rodriguez-Ubreva J, Ballestar E, et al. 2009. A robust and highly efficient immune cell reprogramming system. Cell Stem Cell 5: 554-566.
13. Cai L, Dalal CK, Elowitz MB. 2008. Frequency-modulated nuclear localization bursts coordinate gene regulation. Nature 455: 485-490.
14. Cairns BR. 2009. The logic of chromatin architecture and remodelling at promoters. Nature 461: 193-198.
15. Chakraborty T, Perlot T, Subrahmanyam R, Jani A, Goff PH, Zhang Y, Ivanova I, Alt FW, Sen R. 2009. A 220-nucleotide deletion of the intronic enhancer reveals an epigenetic hierarchy in immunoglobulin heavy chain locus activation. J Exp Med 206: 1019-1027.
16. Chubb JR, Liverpool TB. 2010. Bursts and pulses: Insights fromsingle cell studies into transcriptional mechanisms. Curr Opin Genet Dev 20: 478-484.
17. Cobaleda C, Jochum W, Busslinger M. 2007. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 449: 473-477.
18. Covert MW, Leung TH, Gaston JE, Baltimore D. 2005. Achieving stability of lipopolysaccharide-induced NF-κB activation. Science 309: 1854-1857.
19. Decker T, Pasca di Magliano M, McManus S, Sun Q, Bonifer C, Tagoh H, Busslinger M. 2009. Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis. Immunity 30: 508-520.
20. Degner SC, Verma-Gaur J, Wong TP, Bossen C, Iverson GM, Torkamani A, Vettermann C, Lin YC, Ju Z, Schulz D, et al. 2011. CCCTC-binding factor (CTCF) and cohesin influence the genomic architecture of the Igh locus and antisense transcription in pro-B cells. Proc Natl Acad Sci 108: 9566-9571.
21. Delogu A, Schebesta A, Sun Q, Aschenbrenner K, Perlot T, Busslinger M. 2006. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity 24: 269-281.
22. Deniaud E, Bickmore WA. 2009. Transcription and the nuclear periphery: Edge of darkness? Curr Opin Genet Dev 19: 187-191.
23. De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, Natoli G. 2007. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130: 1083-1094.
24. deWit E, van Steensel B. 2009. Chromatin domains in higher eukaryotes: Insights from genome-wide mapping studies. Chromosoma 118: 25-36.
25. Dias S, Mansson R, Gurbuxani S, Sigvardsson M, Kee BL. 2008. E2A proteins promote development of lymphoid-primed multipotent progenitors. Immunity 29: 217-227.
26. Ebert A, McManus S, Tagoh H, Medvedovic J, Salvagiotto G, Novatchkova M, Tamir I, Sommer A, Jaritz M, Busslinger M. 2011. The distal VH gene cluster of the Igh locus contains distinct regulatory elements with Pax5 transcription factor-dependent activity in pro-B cells. Immunity 34: 175-187.
27. Edmunds JW, Mahadevan LC, Clayton AL. 2008. Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. EMBO J 27: 406-420.
28. Eldar A, Elowitz MB. 2010. Functional roles for noise in genetic circuits. Nature 467: 167-173.
29. Fang TC, Schaefer U, Mecklenbrauker I, Stienen A, Dewell S, Chen MS, Rioja I, Parravicini V, Prinjha RK, Chandwani R, et al. 2012. Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response. J Exp Med 209: 661-669.
30. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, et al. 2010. Selective inhibition of BET bromodomains. Nature 468: 1067-1073.
31. Filippakopoulos P, Picaud S, Mangos M, Keates T, Lambert JP, Barsyte- Lovejoy D, Felletar I, Volkmer R, Muller S, Pawson T, et al. 2012. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 149: 214-231.
32. Foster SL, Hargreaves DC, Medzhitov R. 2007. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978.
33. Fuxa M, Skok J, Souabni A, Salvagiotto G, Roldán E, Busslinger M. 2004. Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene. Genes Dev 18: 411-422.
34. Gilchrist DA, Adelman K. 2012. Coupling polymerase pausing and chromatin landscapes for precise regulation of transcription. Biochim Biophys Acta 1819: 700-706.
35. Gilchrist M, Thorsson V, Li B, Rust AG, Korb M, Roach JC, Kennedy K, Hai T, Bolouri H, Aderem A. 2006. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441: 173-178.
36. Guenther MG, Lawton LN, Rozovskaia T, Frampton GM, Levine SS, Volkert TL, Croce CM, Nakamura T, Canaani E, Young RA. 2008. Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia. Genes Dev 22: 3403-3408.
37. Guo L, Hu-Li J, Paul WE. 2004. Probabilistic regulation of IL-4 production in Th2 cells: Accessibility at the Il4 locus. Immunity 20: 193-203.
38. Guo C, Yoon HS, Franklin A, Jain S, Ebert A, Cheng HL, Hansen E, Despo O, Bossen C, Vettermann C, et al. 2011. CTCF-binding elements mediate control of V(D)J recombination. Nature 477: 424-430.
39. Györy I, Boller S, Nechanitzky R, Mandel E, Pott S, Liu E, Grosschedl R. 2012. Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells. Genes Dev 26: 668-682.
40. Hadjur S, Williams LM, Ryan NK, Cobb BS, Sexton T, Fraser P, Fisher AG, Merkenschlager M. 2009. Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus. Nature 460: 410-413.
41. Hargreaves DC, Horng T, Medzhitov R. 2009. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 138: 129-145.
42. Hawwari A, Krangel MS. 2005. Regulation of TCR d and a repertoires by local and long-distance control of variable gene segment chromatin structure. J Exp Med 202: 467-472.
43. Hesslein DGT, Pflugh DL, Chowdhury D, Bothwell ALM, Sen R, Schatz DG. 2003. Pax5 is required for recombination of transcribed, acetylated, 5′ IgH V gene segments. Genes Dev 17: 37-42.
44. Hewitt SL, Farmer D, Marszalek K, Cadera E, Liang HE, Xu Y, Schlissel MS, Skok JA. 2008. Association between the Igk and Igh immunoglobulin loci mediated by the 3′ Igk enhancer induces 'decontraction' of the Igh locus in pre-B cells. Nat Immunol 9: 396-404.
45. Hewitt SL, Yin B, Ji Y, Chaumeil J, Marszalek K, Tenthorey J, Salvagiotto G, Steinel N, Ramsey LB, Ghysdael J, et al. 2009. RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci. Nat Immunol 10: 655-664.
46. Jaehning JA. 2010. The Paf1 complex: Platform or player in RNA polymerase II transcription? Biochim Biophys Acta 1799: 379-388.
47. Jankovic M, Casellas R, Yannoutsos N, Wardemann H, Nussenzweig MC. 2004. RAGs and regulation of autoantibodies. Annu Rev Immunol 22: 485-501.
48. Jhunjhunwala S, van Zelm MC, Peak MM, Cutchin S, Riblet R, van Dongen JJM, Grosveld FG, Knoch TA, Murre C. 2008. The 3D structure of the immunoglobulin heavy-chain locus: Implications for longrange genomic interactions. Cell 133: 265-279.
49. Jhunjhunwala S, van Zelm MC, Peak MM, Murre C. 2009. Chromatin architecture and the generation of antigen receptor diversity. Cell 138: 435-448.
50. Ji Y, Resch W, Corbett E, Yamane A, Casellas R, Schatz DG. 2010. The in vivo pattern of binding of RAG1 and RAG2 to antigen receptor loci. Cell 141: 419-431.
51. Keats JJ, Reiman T, Maxwell CA, Taylor BJ, Larratt LM, Mant MJ, Belch AR, Pilarski LM. 2003. In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression. Blood 101: 1520-1529.
52. Kim J, Guermah M, McGinty RK, Lee JS, Tang Z, Milne TA, Shilatifard A, Muir TW, Roeder RG. 2009. RAD6-mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells. Cell 137: 459-471.
53. Kosak ST, Skok JA, Medina KL, Riblet R, Le Beau MM, Fisher AG, Singh H. 2002. Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science 296: 158-162.
54. Kuo AJ, Cheung P, Chen K, Zee BM, Kioi M, Lauring J, Xi Y, Park BH, Shi X, Garcia BA, et al. 2011. NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming. Mol Cell 44: 609-620.
55. Kwak H, Fuda NJ, Core LJ, Lis JT. 2013. Precise maps of RNA polymerase reveal how promoters direct initiation and pausing. Science 339: 950-953.
56. Laiosa CV, Stadtfeld M, Xie H, de Andres-Aguayo L, Graf T. 2006. Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBPα and PU.1 transcription factors. Immunity 25: 731-744.
57. Lam FH, Steger DJ, O'Shea EK. 2008. Chromatin decouples promoter threshold from dynamic range. Nature 453: 246-250.
58. Larson DR. 2011. What do expression dynamics tell us about the mechanism of transcription? Curr Opin Genet Dev 21: 591-599.
59. Lee JM, Lee JS, Kim H, Kim K, Park H, Kim JY, Lee SH, Kim IS, Kim J, Lee M, et al. 2012. EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex. Mol Cell 48: 572-586.
60. Li E, Zhang Y. 2014. DNA methylation in mammals. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a019133.
61. Li L, Leid M, Rothenberg EV. 2010. An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. Science 329: 89-93.
62. Lill NL, Grossman SR, Ginsberg D, DeCaprio J, Livingston DM. 1997. Binding and modulation of p53 by p300/CBP coactivators. Nature 387: 823-827.
63. Liu H, Cheng EH, Hsieh JJ. 2009. MLL fusions: Pathways to leukemia. Cancer Biol Ther 8: 1204-1211.
64. Liu Z, Widlak P, Zou Y, Xiao F, Oh M, Li S, Chang MY, Shay JW, Garrard WT. 2006. A recombination silencer that specifies heterochromatin positioning and Ikaros association in the immunoglobulin k locus. Immunity 24: 405-415.
65. Liu H, Schmidt-Supprian M, Shi Y, Hobeika E, Barteneva N, Jumaa H, Pelanda R, Reth M, Skok J, Rajewsky K, et al. 2007. Yin Yang 1 is a critical regulator of B-cell development. Genes Dev 21: 1179-1189.
66. Luo Z, Lin C, Shilatifard A. 2012. The super elongation complex (SEC) family in transcriptional control. Nat Rev Mol Cell Biol 13: 543-547.
67. Maheshri N, O'Shea EK. 2007. Living with noisy genes: How cells function reliably with inherent variability in gene expression. Annu Rev Biophys Biomol Struct 36: 413-434.
68. Malin S, McManus S, Cobaleda C, Novatchkova M, Delogu A, Bouillet P, Strasser A, Busslinger M. 2010. Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development. Nat Immunol 11: 171-179.
69. Mar BG, Bullinger L, Basu E, Schlis K, Silverman LB, Döhner K, Armstrong SA. 2012. Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia. Leukemia 26: 1881-1883.
70. Marazzi I, Ho JS, Kim J, Manicassamy B, Dewell S, Albrecht RA, Seibert CW, Schaefer U, Jeffrey KL, Prinjha RK, et al. 2012. Suppression of the antiviral response by an influenza histone mimic. Nature 483: 428-433.
71. Matthews AG, Kuo AJ, Ramón-Maiques S, Han S, Champagne KS, Ivanov D, Gallardo M, Carney D, Cheung P, Ciccone DN, et al. 2007. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature 450: 1106-1110.
72. McManus S, Ebert A, Salvagiotto G, Medvedovic J, Sun Q, Tamir I, Jaritz M, Tagoh H, Busslinger M. 2011. The transcription factor Pax5 regulates its target genes by recruiting chromatin-modifying proteins in committed B cells. EMBO J 30: 2388-2404.
73. Medvedovic J, Ebert A, Tagoh H, Busslinger M. 2011. Pax5: A master regulator of B cell development and leukemogenesis. Adv Immunol 111: 179-206.
74. H gene region of the Igh locus facilitate the generation of a diverse antibody repertoire. Immunity 39: 229-244.
75. Medzhitov R. 2008. Origin and physiological roles of inflammation. Nature 454: 428-435.
76. Medzhitov R, Horng T. 2009. Transcriptional control of the inflammatory response. Nat Rev Immunol 9: 692-703.
77. Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R, Paul JE, Boyle M, Woolcock BW, Kuchenbauer F, et al. 2010. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 42: 181-185.
78. Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, et al. 2011. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476: 298-303.
79. Mujtaba S, Zeng L, Zhou MM. 2007. Structure and acetyl-lysine recognition of the bromodomain. Oncogene 26: 5521-5527.
80. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, Girtman K, Mathew S, Ma J, Pounds SB, et al. 2007. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446: 758-764.
81. Mullighan CG, Zhang J, Kasper LH, Lerach S, Payne-Turner D, Phillips LA, Heatley SL, Holmfeldt L, Collins-Underwood JR, Ma J, et al. 2011. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 471: 235-239.
82. Murphy KM. 2005. Fate vs choice: The immune system reloaded. Immunol Res 32: 193-200.
83. Nativio R, Wendt KS, Ito Y, Huddleston JE, Uribe-Lewis S, Woodfine K, Krueger C, Reik W, Peters JM, Murrell A. 2009. Cohesin is required for higher-order chromatin conformation at the imprinted IGF2-H19 locus. PLoS Genet 5: e1000739.
84. Natoli G, Ghisletti S, Barozzi I. 2011. The genomic landscapes of inflammation. Genes Dev 25: 101-106.
85. Ng SY-M, Yoshida T, Zhang J, Georgopoulos K. 2009. Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells. Immunity 30: 493-507.
86. Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, Chung CW, Chandwani R, Marazzi I, Wilson P, Coste H, et al. 2010. Suppression of inflammation by a synthetic histone mimic. Nature 468: 1119-1123.
87. Ntziachristos P, Tsirigos A, Van Vlierberghe P, Nedjic J, Trimarchi T, Flaherty MS, Ferres-Marco D, da Ros V, Tang Z, Siegle J, et al. 2012. Genetic inactivation of the Polycomb repressive complex 2 in T cell acute lymphoblastic leukemia. Nat Med 18: 298-301.
88. Nutt SL, Kee BL. 2007. The transcriptional regulation of B cell lineage commitment. Immunity 26: 715-725.
89. Nutt SL, Heavey B, Rolink AG, Busslinger M. 1999. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401: 556-562.
90. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-959.
91. Oguro H, Yuan J, Ichikawa H, Ikawa T, Yamazaki S, Kawamoto H, Nakauchi H, Iwama A. 2010. Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1. Cell Stem Cell 6: 279-286.
92. Okada Y, Feng Q, Lin Y, Jiang Q, Li Y, Coffield VM, Su L, Xu G, Zhang Y. 2005. hDOT1L links histone methylation to leukemogenesis. Cell 121: 167-178.
93. Paixao T, Carvalho TP, Calado DP, Carneiro J. 2007.Quantitative insights into stochastic monoallelic expression of cytokine genes. Immunol Cell Biol 85: 315-322.
94. Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, Kasper LH, Lerach S, Tang H, Ma J, et al. 2011. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471: 189-195.
95. Pedraza JM, Paulsson J. 2008. Effects of molecular memory and bursting on fluctuations in gene expression. Science 319: 339-343.
96. Perlot T, Alt FW. 2008. Cis-regulatory elements and epigenetic changes control genomic rearrangements of the IgH locus. Adv Immunol 99: 1-32.
97. Perlot T, Alt FW, Bassing CH, Suh H, Pinaud E. 2005. Elucidation of IgH intronic enhancer functions via germ-line deletion. Proc Natl Acad Sci 102: 14362-14367.
98. Peterlin BM, Price DH. 2006. Controlling the elongation phase of transcription with P-TEFb. Mol Cell 23: 297-305.
99. Phillips JE, Corces VG. 2009. CTCF: Master weaver of the genome. Cell 137: 1194-1211.
100. Radtke F, Fasnacht N, Macdonald HR. 2010. Notch signaling in the immune system. Immunity 32: 14-27.
101. Raj A, van Oudenaarden A. 2009. Single-molecule approaches to stochastic gene expression. Annu Rev Biophys 38: 255-270.
102. Ramirez-Carrozzi VR, Braas D, Bhatt DM, Cheng CS, Hong C, Doty KR, Black JC, Hoffmann A, Carey M, Smale ST. 2009. Aunifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 138: 114-128.
103. Raser JM, O'Shea EK. 2005. Noise in gene expression: Origins, consequences, and control. Science 309: 2010-2013.
104. Revilla-i-Domingo R, Bilic I, Vilagos B, Tagoh H, Ebert A, Tamir IM, Smeenk L, Trupke J, Sommer A, Jaritz M, et al. 2012. The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis. EMBO J 31: 3130-3146.
105. Ribeiro de Almeida C, Stadhouders R, de Bruijn MJ, Bergen IM, Thongjuea S, Lenhard B, van Ijcken W, Grosveld F, Galjart N, Soler E, et al. 2011. The DNA-binding protein CTCF limits proximal Vk recombination and restricts k enhancer interactions to the immunoglobulin k light chain locus. Immunity 35: 501-513.
106. Roldán E, Fuxa M, Chong W, Martinez D, Novatchkova M, Busslinger M, Skok JA. 2005. Locus 'decontraction' and centromeric recruitment contribute to allelic exclusion of the immunoglobulin heavy-chain gene. Nat Immunol 6: 31-41.
107. Romanow WJ, Langerak AW, Goebel P, Wolvers-Tettero ILM, van Dongen JJM, Feeney AJ, Murre C. 2000. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol Cell 5: 343-353.
108. Saccani S, Natoli G. 2002. Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. Genes Dev 16: 2219-2224.
109. Sampath SC, Marazzi I, Yap KL, Sampath SC, Krutchinsky AN, Mecklenbrauker I, Viale A, Rudensky E, Zhou MM, Chait BT, et al. 2007. Methylation of a histone mimic within the histone methyltransferase G9a regulates protein complex assembly. Mol Cell 27: 596-608.
110. Sayegh C, Jhunjhunwala S, Riblet R, Murre C. 2005. Visualization of looping involving the immunoglobulin heavy-chain locus in developing B cells. Genes Dev 19: 322-327.
111. Schlimgen RJ, Reddy KL, Singh H, Krangel MS. 2008. Initiation of allelic exclusion by stochastic interaction of Tcrb alleles with repressive nuclear compartments. Nat Immunol 9: 802-809.
112. Seitan VC, Hao B, Tachibana-Konwalski K, Lavagnolli T, Mira-Bontenbal H, Brown KE, Teng G, Carroll T, Terry A, Horan K, et al. 2011. A role for cohesin in T-cell-receptor rearrangement and thymocyte differentiation. Nature 476: 467-471.
113. Shaffer AL, Lin K-I, Kuo TC, Yu X, Hurt EM, Rosenwald A, Giltnane JM, Yang L, Zhao H, Calame K, et al. 2002. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17: 51-62.
114. Simon C, Chagraoui J, Krosl J, Gendron P, Wilhelm B, Lemieux S, Boucher G, Chagnon P, Drouin S, Lambert R, et al. 2012. A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia. Genes Dev 26: 651-656.
115. Skok JA, Gisler R, Novatchkova M, Farmer D, de Laat W, Busslinger M. 2007. Reversible contraction by looping of the Tcrb and Tcra loci in rearranging thymocytes. Nat Immunol 8: 378-387.
116. Smale ST. 2010a. Pioneer factors in embryonic stem cells and differentiation. Curr Opin Genet Dev 20: 519-526.
117. Smale ST. 2010b. Selective transcription in response to an inflammatory stimulus. Cell 140: 833-844.
118. Smith E, Shilatifard A. 2010. The chromatin signaling pathway: Diverse mechanisms of recruitment of histone-modifying enzymes and varied biological outcomes. Mol Cell 40: 689-701.
119. Sneeringer CJ, Scott MP, Kuntz KW, Knutson SK, Pollock RM, Richon VM, Copeland RA. 2010. Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas. Proc Natl Acad Sci 107: 20980-20985.
120. Splinter E, Heath H, Kooren J, Palstra R-J, Klous P, Grosveld F, Galjart N, de Laat W. 2006. CTCF mediates long-range chromatin looping and local histone modification in the β-globin locus. Genes Dev 20: 2349-2354.
121. Stanhope-Baker P, Hudson KM, Shaffer AL, Constantinescu A, Schlissel MS. 1996. Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro. Cell 85: 887-897.
122. Stevense M, Muramoto T, Muller I, Chubb JR. 2010. Digital nature of the immediate-early transcriptional response. Development 137: 579-584.
123. Su I-H, Basavaraj A, Krutchinsky AN, Hobert O, Ullrich A, Chait BT, Tarakhovsky A. 2003. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat Immunol 4: 124-131.
124. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
125. Tay S, Hughey JJ, Lee TK, Lipniacki T, Quake SR, Covert MW. 2010. Single-cell NF-κB dynamics reveal digital activation and analogue information processing. Nature 466: 267-271.
126. Ting CN, Olson MC, Barton KP, Leiden JM. 1996. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 384: 474-478.
127. van Haaften G, Dalgliesh GL, Davies H, Chen L, Bignell G, Greenman C, Edkins S, Hardy C, O'Meara S, Teague J, et al. 2009. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet 41: 521-523.
128. Weber BN, Chi AW-S, Chavez A, Yashiro-Ohtani Y, Yang Q, Shestova O, Bhandoola A. 2011. A critical role for TCF-1 in T-lineage specification and differentiation. Nature 476: 63-68.
129. Xiang Y, Zhou X, Hewitt SL, Skok JA, Garrard WT. 2011. A multifunctional element in the mouse Igk locus that specifies repertoire and Ig loci subnuclear location. J Immunol 186: 5356-5366.
130. Xie H, Ye M, Feng R, Graf T. 2004. Stepwise reprogramming of B cells into macrophages. Cell 117: 663-676.
131. Yancopoulos GD, Alt FW. 1985. Developmentally controlled and tissuespecific expression of unrearranged VH gene segments. Cell 40: 271-281.
132. Yap DB, Chu J, Berg T, Schapira M, Cheng SW, Moradian A, Morin RD, Mungall AJ, Meissner B, Boyle M, et al. 2011. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood 117: 2451-2459.
133. Ye S-K, Agata Y, Lee H-C, Kurooka H, Kitamura T, Shimizu A, Honjo T, Ikuta K. 2001. The IL-7 receptor controls the accessibility of the TCRγ locus by Stat5 and histone acetylation. Immunity 15: 813-823.
134. Yosef N, Regev A. 2011. Impulse control: Temporal dynamics in gene transcription. Cell 144: 886-896.
135. Zak DE, Aderem A. 2009. Systems biology of innate immunity. Immunol Rev 227: 264-282.
136. Zeng L, Zhou MM. 2002. Bromodomain: An acetyl-lysine binding domain. FEBS Lett 513: 124-128.
137. Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, Chen X, Wang J, Rusch M, et al. 2012a. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481: 157-163.
138. Zhang J, Jackson AF, Naito T, Dose M, Seavitt J, Liu F, Heller EJ, Kashiwagi M, Yoshida T, Gounari F, et al. 2012b. Harnessing of the nucleosome-remodeling-deacetylase complex controls lymphocyte development and prevents leukemogenesis. Nat Immunol 13: 86-94.
139. Zhao M, Zhang J, Phatnani H, Scheu S, Maniatis T. 2012. Stochastic expression of the interferon-β gene. PLoS Biol 10: e1001249.
140. Zhou Q, Li T, Price DH. 2012. RNA polymerase II elongation control. Annu Rev Biochem 81: 119-143.